Clinical Trial Update: HR+/ HER2- Advanced/ Metastatic Breast Cancer Real World Treatment Patterns and Outcomes

View source ↗

Summary

A terminated clinical trial evaluating real-world treatment patterns and outcomes in HR+/HER2- advanced/metastatic breast cancer, with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pfizer

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Status: TERMINATED | Results posted: 2022-03-21